11 March 2015
Cyclops and Thinkware announce innovative content partnership
Cyclops today announces a new partnership with Thinkware, the leading Korean IT and location based services provider. Thinkware is well-known for its smart platform services ranging from car navigation to dashboard cameras. In this first collaboration, Thinkware has included...
2 March 2015
Biofortuna appoints new Chairman
Wirral-based molecular diagnostics company Biofortuna has appointed a new chairman to lead the next phase of growth. Life sciences expert Ian Johnson will take on the role at Biofortuna, which specialises in freeze-dried diagnostics and contract services, with previous chairman...
26 February 2015
r2c Online software Aids Compliance for Leeds Commercial Vehicle Hire
LC Vehicle Hire, a nationwide commercial vehicle rental specialist, has become the latest company to choose the r2c Online software solution for their fleet management. Pat Graham, LC Vehicle Hire Operations Director, was central in choosing the r2c Online platform and explained...
10 February 2015
Andy Hill Appointed Chief Executive Officer at Michelson Diagnostics
Orpington, UK, 2 February 2015 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces the appointment of Andy Hill as Chief Executive Officer, effective from 1 February 2015.
5 February 2015
Monica Healthcare completes new £2 million Investment round
NOTTINGHAM, UK, 30 January 2015 – Monica Healthcare today announced that it has raised new investment totalling £2 million from existing shareholders and new investors. Originally planned as a £1.5 million fundraise, the round was heavily oversubscribed. Monica...
3 February 2015
Biofortuna Ltd closes a £1.5m funding round
Biofortuna Ltd, the UK based molecular diagnostics company specialising in its proprietary freeze dried diagnostics and contract services, announces raising £1.5m in its latest funding round. The £1.5m funding was supported by all the company’s current...
20 January 2015
Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim
Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to an Oncology Target … OXFORD, England, January 14, 2015 /PRNewswire/ -- Oxford BioTherapeutics announces today that Boehringer Ingelheim has...
13 January 2015
Antitope, INSERM and Baylor Institute to collaborate to produce manufacturing cell lines for two novel vaccines for HIV
Cambridge, UK – Antitope Limited (“Antitope”), an Abzena company (AIM: ABZA) that provides services and technologies to enable the development of better biopharmaceuticals, announces that it has extended its relationship with INSERM, the French National...
3 December 2014
Comply Serve wins at Construction Computing Awards
Comply Serve is thrilled to announce that our progressive assurance software, ComplyPro, has won the Cloud Based Technology Of The Year category at the Construction Computing awards. Impressively Comply Serve was a runner up in two other categories: Infrastructure Project Of The...
26 November 2014
OBT and Menarini announce start of first-in-human clinical study to treat acute myeloid leukemia
$1 Billion Oncology Alliance between Menarini Group & Oxford BioTherapeutics Initiates First-in-Human Study of Enhanced Antibody for Treatment of Acute Myeloid Leukemia … OXFORD, UK and BERLIN, GERMANY– 25 November 2014 – Oxford BioTherapeutics and Berlin Chemie...